SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Pre-close update

30 Jun 2020 07:00

RNS Number : 4440R
Rotork PLC
30 June 2020
 

Rotork Plc

Pre-close update

30 June 2020

Rotork Plc, the global flow control and instrumentation Group, issues the following update prior to entering our interim results close period.

COVID-19 update

Our priority is the health and safety of our colleagues and their families, our customers, suppliers and all other stakeholders. We continue to take decisive actions to manage the COVID-19 situation whilst following the instructions from governments and health authorities.

Kevin Hostetler, Chief Executive said "I would like to recognise the extraordinary fortitude and determination of all our people in recent months, be they in our factories, in Rotork Site Services, in our offices or currently working from home. Thanks to all their hard work Rotork will emerge stronger than ever. I am also really proud of their efforts supporting our local communities."

Since our trading update on 31 March the near-term outlook has become a little clearer, but there remains considerable uncertainty, including potential further COVID-19 impacts.

All our production facilities are currently open, albeit in a small number of cases operating at below normal output levels, with reconfigured layouts and processes and equipment to allow safe distancing between our employees. Whilst we are planning to keep our facilities open we will not hesitate to close them again if required or if we believe there is any risk to our colleagues or their families.

Trading update

Despite the unprecedented economic environment trading has held up reasonably well.

Based on trading to mid June 2020 we anticipate that, subject to the timing of receipt of expected orders, Group order intake in the first half will be circa 16-18% lower than the previous year's £362m on an OCC¹ basis, with Asia Pacific orders modestly lower year on year (YoY) and demand in the EMEA region holding up better than that in the Americas.

Oil & Gas orders are expected to be down slightly more than the Group, with the upstream most impacted. Downstream orders are likely to hold up better but still be down YoY.

Water & Power provides essential products and services and we anticipate a resilient performance from the division. Incoming orders are anticipated to be lower YoY reflecting the strong prior year period.

Chemical, Process & Industrial ("CPI") orders are likely to be down YoY, but less than the Group. Process demand is expected to hold up better than other CPI end markets with the HVAC segment particularly busy.

Group revenues are anticipated to have declined in the first half, reflecting COVID-19 related disruption to our factories, supply chains, logistics and to Rotork Site Services. This disruption peaked in April and has reduced steadily since, albeit we are not yet back to normal. In the April - May period, revenues were down 14% YoY on an OCC basis equalised for working weeks. We anticipate that, subject to no additional COVID-19 related disruption, Group revenues in the first half will be circa 11-13% down YoY, and whilst adjusted Group operating profits will be lower, margins will be relatively resilient.

Update on mitigating actions

We announced on 31 March 2020 the mitigating actions we would be taking to reduce the impact of COVID-19 on our business. These actions included a recruitment freeze, postponing salary increases, restricting discretionary spend, drawing on government wage replacement schemes and flexibility with the workforce. These benefited our performance in April and May.

We are in the process of accelerating some restructuring actions that we had planned for the latter years of the Growth Acceleration Programme. The cost of these restructuring actions is expected to be circa £2m in the first half. We have also deferred the commencement of some parts of our IT upgrade, reducing our planned capital expenditure for this year by a similar amount.

Financial position and bank facility update

Rotork remains highly cash generative and we maintain a strong balance sheet. The Group had £125.6m of net cash as at 31 May 2020. We recently entered into a new committed two-year revolving credit facility with our banks. The facility, which is undrawn, is for £60m.

Outlook

Due to the unprecedented level of uncertainty, on 31 March we withdrew our forward guidance for the current year. Whilst the near-term outlook has become a little clearer, there remains considerable uncertainty, hence we retain this position. We are confident however that we will successfully navigate the current challenges and will be a stronger business going forward. Our confidence comes in no small part from the success to date of our Growth Acceleration Programme initiatives which have already demonstrably increased Rotork's cyclical resilience.

We expect to publish our half-year results on Tuesday 4 August 2020.

A conference call for analysts and investors will be held at 8:00 BST today to discuss this statement.

The dial-in details are as follows:

UK dial-in number: 020 3936 2999

All other locations: +44 20 3936 2999

Access code: 396394

¹OCC is organic constant currency results which exclude discontinued businesses from 2019 results and 2020 results are restated at 2019 exchange rates.

 

Historical results under our new divisional structure

Following the completion of the implementation of our new market aligned structure, Rotork will now report under three divisions: Oil & Gas, Water & Power, and Chemical, Process & Industrial ("CPI"). This realignment is an important element of our Growth Acceleration Programme and means our client facing teams now sell to specific end markets. The new structure will more closely address customer needs and facilitate closer customer relations through key account management. Further information on our restatement methodology will be provided with our half-year results. The table below shows Rotork's historical results from 2017 onwards analysed by each new division.

£m

2017

2018

2019

H1 2019

 

 

 

 

 

Oil & Gas

 

 

 

 

Revenue

306.7

345.7

330.0

158.1

Adjusted operating profit

62.7

75.1

75.5

34.8

Adjusted operating profit margin

20.4%

21.7%

22.9%

22.0%

 

 

 

 

 

Water & Power

 

 

 

 

Revenue

172.7

159.8

154.9

69.1

Adjusted operating profit

41.6

41.1

45.1

18.0

Adjusted operating profit margin

24.1%

25.7%

29.1%

26.0%

 

 

 

 

 

Chemical, Process & Industrial

 

 

 

 

Revenue

162.8

190.2

184.4

91.4

Adjusted operating profit

33.8

40.7

42.0

19.8

Adjusted operating profit margin

20.8%

21.4%

22.8%

21.6%

 

 

 

 

 

Unallocated costs

-7.9

-10.9

-11.6

-5.4

 

 

 

 

 

Group

 

 

 

 

Revenue

642.2

695.7

669.3

318.6

Adjusted operating profit

130.2

146.0

151.0

67.2

Adjusted operating profit margin

20.3%

21.0%

22.6%

21.1%

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBIGDLXXDDGGC
Date   Source Headline
11th Jun 202612:08 pmRNSDirector/PDMR Shareholding
1st Jun 20269:34 amRNSTotal Voting Rights
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20265:57 pmRNSDirector/PDMR Shareholding
12th May 202612:25 pmRNSDirector/PDMR Shareholding
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:45 amRNSResult of AGM
1st May 20269:53 amRNSTotal Voting Rights
1st May 20267:00 amRNSTrading update
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202610:49 amRNSDirector/PDMR Shareholding
21st Apr 20264:58 pmRNSHolding(s) in Company
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20263:18 pmRNSDirector/PDMR Shareholding
15th Apr 20261:19 pmRNSShare buyback programme
13th Apr 20264:37 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20268:52 amRNSDirector/PDMR Shareholding
7th Apr 20269:52 amRNSTransaction in Own Shares - Clarification Notice
7th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20269:10 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20263:03 pmRNS2025 Annual Report and Notice of 2026 AGM
26th Mar 20261:55 pmRNSDirector/PDMR Shareholding
25th Mar 202611:36 amRNSDirector/PDMR Shareholding
23rd Mar 20262:38 pmRNSHolding(s) in Company
23rd Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 202611:01 amRNSDirector/PDMR Shareholding
13th Mar 20261:54 pmRNSShare buyback programme
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 full year results
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20261:16 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.